January/February 2012, Vol 5, No 1

Regulatory

Primary Care Shortages: Strengthening This Sector Is Urgently Needed, Now and in Preparation for Healthcare Reform
Sarah Collins, MBA
Stakeholder Perspective by Gary M. Owens, MD

Clinical

Daily Average Consumption of 2 Long-Acting Opioids: An Interrupted Time Series Analysis
R. Amy Puenpatom, PhD
; Sheryl L. Szeinbach, PhD, RPh
; Larry Ma, PhD
; Rami H. Ben-Joseph, PhD
; Kent H. Summers, PhD, BSPharm
Stakeholder Perspective by Matthew Mitchell, PharmD, MBA

Business

Beyond the Cost of Biologics: Employer Survey Reveals Gap in Understanding Role of Specialty Pharmacy and Benefit Design
F. Randy Vogenberg, RPh, PhD
; Cheryl Larson, BA
; Margaret Rehayem, MA
; Larry Boress, MPA
Stakeholder Perspective by Atheer A. Kaddis, PharmD

Editorial

The Business Case for Ending Homelessness: Having a Home Improves Health, Reduces Healthcare Utilization and Costs
Daniel G. Garrett, RPh, MS, FASHP
American Health & Drug Benefits: Reflections on the First 5 Years
Gary M. Owens, MD

Industry Trends

Employers, Health Plans, and New Drug Benefit Designs: A Shifting Landscape
Mark Zitter, MBA
; Michael Snyder